Cas:5445-24-9 1-propylcyclohexan-1-ol manufacturer & supplier

We serve Chemical Name:1-propylcyclohexan-1-ol CAS:5445-24-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-propylcyclohexan-1-ol

Chemical Name:1-propylcyclohexan-1-ol
CAS.NO:5445-24-9
Synonyms:1-Hydroxy-1-propyl-cyclohexan;propylcyclohexyl alcohol;MFCD0004636;1-n-propyl-1-cyclohexanol;1-Propylcyclohexanol;1-n-PROPYL CYCLOHEXANOL-1;Cyclohexanol,1-propyl
Molecular Formula:C9H18O
Molecular Weight:142.23900
HS Code:2906199090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:194.4ºC at 760mmHg
Density:0.912g/cm3
Index of Refraction:1.465
PSA:20.23000
Exact Mass:142.13600
LogP:2.48170

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-Hydroxy-1-propyl-cyclohexan chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Cyclohexanol,1-propyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,propylcyclohexyl alcohol Use and application,1-n-propyl-1-cyclohexanol technical grade,usp/ep/jp grade.


Related News: We are committed to bringing safe, effective vaccines to Ireland and other markets as quickly as possible, and Charles River will continue to be an important partner in this regard.” 1-(2-methoxy-5-nitrophenyl)-N-phenylmethanimine manufacturers Sales for Tafinlar and Mekinist, the MEK inhibitor it was approved with, hit $672 million in 2016. Fast forward to 2020 and the duo generated $1.5 billion in revenue. 4-amino-1,2-dimethyl-chromeno[3,4-c]pyridin-5-one suppliers “In the past few years, the pharmaceutical industry has seen rapid growth driven by the growth of small molecules’ innovations, complex APIs and the increasing need to optimize available resources. α-methylthio-3-chloro-4-allyloxyphenylacetic acid vendor & factory “In the past few years, the pharmaceutical industry has seen rapid growth driven by the growth of small molecules’ innovations, complex APIs and the increasing need to optimize available resources. ,We are committed to bringing safe, effective vaccines to Ireland and other markets as quickly as possible, and Charles River will continue to be an important partner in this regard.”